Acetate
- Generic Name
- Acetate
- Drug Type
- Small Molecule
- Chemical Formula
- C2H3O2
- CAS Number
- 71-50-1
- Unique Ingredient Identifier
- 569DQM74SC
SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain
- Conditions
- Endometriosis Related Pain
- Interventions
- First Posted Date
- 2017-07-02
- Last Posted Date
- 2021-06-28
- Lead Sponsor
- Myovant Sciences GmbH
- Target Recruit Count
- 623
- Registration Number
- NCT03204331
- Locations
- πΊπΈ
Aventura, Aventura, Florida, United States
πΊπΈHialeah, Hialeah, Florida, United States
πΊπΈIdaho Falls, Idaho Falls, Idaho, United States
LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
- Conditions
- Uterine FibroidHeavy Menstrual Bleeding
- Interventions
- First Posted Date
- 2017-04-06
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Myovant Sciences GmbH
- Target Recruit Count
- 382
- Registration Number
- NCT03103087
- Locations
- πΊπΈ
Dallas, Dallas, Texas, United States
πΏπ¦Cape Town, Cape Town, Western Cape, South Africa
π¨πΏOstrava, Ostrava, Czechia
LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
- Conditions
- Heavy Menstrual BleedingUterine Fibroid
- Interventions
- First Posted Date
- 2017-02-10
- Last Posted Date
- 2022-04-19
- Lead Sponsor
- Myovant Sciences GmbH
- Target Recruit Count
- 388
- Registration Number
- NCT03049735
- Locations
- πΊπΈ
Clearwater, Clearwater, Florida, United States
πΊπΈHialeah, Hialeah, Florida, United States
πΊπΈChattanooga, Chattanooga, Tennessee, United States
Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause
- Conditions
- Heavy Menstrual BleedingImprove Quality of Life
- Interventions
- Drug: combined contraceptive pills (microcept)
- First Posted Date
- 2016-10-25
- Last Posted Date
- 2021-06-04
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 240
- Registration Number
- NCT02943655
- Locations
- πͺπ¬
Ahmed Abbas, Assiut, Cairo, Egypt
An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
- Conditions
- Uterine FibroidsHeavy Menstrual Bleeding
- Interventions
- First Posted Date
- 2016-10-06
- Last Posted Date
- 2021-07-13
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 433
- Registration Number
- NCT02925494
- Locations
- πΊπΈ
Choice Research, LLC /ID# 153492, Dothan, Alabama, United States
πΊπΈNECCR Fall River LLC /ID# 153274, Fall River, Massachusetts, United States
πΊπΈMount Vernon Clinical Res, LLC /ID# 153403, Atlanta, Georgia, United States
Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients
- Conditions
- Clinically Diagnosed Endometriotic Patient Was Defined as a Woman Who Has Pelvic Pain and at Least One Evidence of PV or TVS
- Interventions
- Device: LNG-IUS
- First Posted Date
- 2016-09-09
- Last Posted Date
- 2016-09-09
- Lead Sponsor
- Chulalongkorn University
- Target Recruit Count
- 50
- Registration Number
- NCT02894151
C11 Sodium Acetate PET/CT Imaging of PCa
- Conditions
- Prostate Cancer
- First Posted Date
- 2016-07-11
- Last Posted Date
- 2020-07-24
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT02826395
- Locations
- πΊπΈ
200 Medical Plaza, B114, Los Angeles, California, United States
Estrogen Diastolic Heart Failure
- First Posted Date
- 2016-02-26
- Last Posted Date
- 2018-08-08
- Lead Sponsor
- Gretchen Wells
- Target Recruit Count
- 4
- Registration Number
- NCT02693002
- Locations
- πΊπΈ
University of Kentucky, Lexington, Kentucky, United States
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)
- Conditions
- Heavy Menstrual BleedingUterine Fibroids
- Interventions
- Drug: Placebo for Estradiol/Norethindrone Acetate
- First Posted Date
- 2016-02-25
- Last Posted Date
- 2021-07-13
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 378
- Registration Number
- NCT02691494
- Locations
- πΊπΈ
University of California, Los Angeles /ID# 149760, Los Angeles, California, United States
πΊπΈMount Vernon Clinical Res, LLC /ID# 144297, Atlanta, Georgia, United States
πΊπΈClinical Trial Investigators /ID# 152470, Tustin, California, United States
Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women
- Conditions
- Uterine FibroidsHeavy Menstrual Bleeding
- Interventions
- Drug: Placebo for Estradiol/Norethindrone Acetate
- First Posted Date
- 2016-01-13
- Last Posted Date
- 2020-06-29
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 413
- Registration Number
- NCT02654054
- Locations
- πΊπΈ
Houston Ctr for Clin Research /ID# 149149, Sugar Land, Texas, United States
πΊπΈFellows Research Alliance, Inc /ID# 139655, Savannah, Georgia, United States
πΊπΈUniversity of California, Los Angeles /ID# 144107, Los Angeles, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.